查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球皮肤填充剂市场-2022-2029
市场调查报告书
商品编码
1146447

全球皮肤填充剂市场-2022-2029

Global Dermal Fillers Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期间（2022-2029 年），全球真皮填充剂市场规模预计将以 11.10% 的复合年增长率增长。

皮肤填充剂是一种注射剂，在服用时可以抚平面部皱纹并抚平细纹。医疗保健专业人员通常将真皮填充剂注射到眼睛、嘴巴和鼻子附近的区域。这种备受期待的整容程序通常直接产生效果并持续数月至数年。

市场动态

全球皮肤填充剂市场受到技术进步、皮肤填充剂在医疗和美容手术中的使用增加、患者意识提高以及美容手术支出增加的推动。

提高公众对医疗和美容护理的认识推动市场增长

在预测期内，抗衰老需求的增加和社交媒体意识的提高将推动市场。根据 2022 年 4 月发表在《美容外科杂誌》上的一篇文章，技术的进步和社交媒体的普及提高了人们对各种美容标准和审美结果的认识，最终导致了对美、吸引力和治疗目标的定义。传播。相反，客户在美容医学上的支出急剧增加，为未来的美容医学市场创造了广阔的前景。

大约 70% 的受访医生回答说他们应该在 20 多岁和 30 多岁时接受美容医学。此外，在美感高的女性中，32%的30多岁女性和37%的40多岁女性回答应该接受治疗。

此外，在社交媒体时代，真皮填充剂市场正在发展，以通过平衡面部来吸引年轻一代。这些治疗旨在增强和保持年轻，而不是纠正与年龄相关的变化，包括下巴轮廓、丰唇、液体隆鼻和软糖微笑矫正。

此外，真皮填充剂用于扩大面部以满足美容的审美概念，满足特定的曲线、轮廓、尺寸和比例，以拥有传统迷人的面部。或用于重塑老化的面部，从而使其青春。与永久性外科美容手术相比，使用软组织可生物降解填充物（一种非永久性注射装置）进行面部重建是一种经济实惠且相对安全的手术。

真皮填充剂的副作用阻碍市场增长

但是，注射部位周围的常见副作用是立竿见影的：发红、肿胀、疼痛、瘀伤、瘙痒和皮疹。罕见的副作用包括注射部位的填充剂渗漏、肉芽肿、感染、填充剂的炎症反应、注射部位周围的结节、填充剂从一个部位迁移到另一个部位以及血管损伤增加。这些副作用限制了市场增长。

COVID-19 影响分析

COVID-19 的出现对全球医疗和美容市场产生了相当大的影响。正如 2022 年 9 月发表的文章，整容手术和美容干预更像是一种生活方式的奢侈品，而不是必需品。在 COVID 流行开始时执行的程序数量已显着减少。

但是，保持社交距离的做法导致人们花更多时间在视频通话上，从而加剧了对自己外表的不满，有时还会促使人们对身体，尤其是面部产生异常想法，从而导致： 对美容和美容治疗的需求增加。

另一方面，与 SARS-CoV-2 感染相关的疫苗会导致过去接受过美容或美容手术的人出现皮肤反应。此外，在灾难或危机之后，对改善身心自我接纳的需求通常会增加，COVID-19 也不例外。

截至 2022 年，它已从 COVID-19 中恢復过来，几乎所有人都可以使用医疗保健和美容设施，它正在推动全球市场。

细分分析

透明质酸 (HA) 细分市场预计将在预测期间（2022-2029 年）以最快的复合年增长率增长。

透明质酸 (HA) 细分市场占有最大的市场份额。可注射 HA 填充剂的普及使它们上升到时尚的地位。它导致以前罕见的异位血管闭塞性损伤的发生率随之增加，从面部皮肤坏死到神经眼科后遗症。

根据发表在 Molecules 2022 上的一篇文章，自 2005 年至 2020 年 HA 注射凝胶的销量飙升 700% 以来，真皮填充剂的受欢迎程度已达 20 年。截至 2022 年，全球化妆品填充剂市场预测到 2030 年将达到 65%。

化学交联透明质酸（HA，透明质酸）凝胶衍生物的出现，为外科、再生医学和药理学带来了新的治疗应用，标誌着生物医学领域的新纪元。然而，近年来最显着的增长可能是在美容医学中使用基于水胶体 HA 的真皮填充剂。这些可注射 HA 凝胶的爆炸性使用导致由于意外血管内註射凝胶体积而导致轻微缺血性组织梗塞的发生率随之增加，从而导致填充物阻塞血管。

区域分析

北美在全球真皮填充剂市场占有最大的市场份额

北美在真皮填充剂市场上占主导地位，预计在预测期内将显示出类似的趋势。市场受到先进医疗基础设施等因素的推动。这是由于医疗和美容意识的提高、该地区主要参与者的活动以及该地区产品的现成供应。

根据发表在 Molecules 2022 上的一篇文章，仅在美国每年就进行大约 340 万次皮肤填充程序，其中大约 80% 的填充剂产品由 HA 填充剂组成。对美容注射剂的这种不断增长的需求是由于所有年龄和性别群体对整形手术的接受程度越来越高，获得和营销的改善，以及产品成本的降低，促进了进一步的采用。我们正在创造一个似乎是竞争激烈的市场。

此外，市场参与者正在采用合作和产品发布等市场策略来扩展业务。例如，2020 年 5 月，艾伯维（AbbVie）收购艾尔建（Allergan）以扩大业务。艾尔建拥有一系列品牌和一流产品，主要专注于四大治疗领域：医学美容、眼部护理、中枢神经系统和胃肠系统。

竞争格局

真皮填充剂市场是一个来自本地和全球参与者的适度竞争市场。为市场增长做出贡献的主要公司包括 Allergan plc、Galderma、Merz Pharma、Sinclair Pharma plc、AQTIS Medical、Teoxane Laboratories、Cytophil Inc、Cynosure、Dr. Korman Laboratories Ltd.，而 Advanced Aesthetic Technologies Inc. 是主要参与者采用了多种增长战略，例如产品发布、收购和合作伙伴关係，为真皮填充剂市场的全球增长做出了贡献。

产品组合

JUVEDERM：JUVEDERM 系列透明质酸真皮填充剂可修復中度至重度面部皱纹和褶皱。

全球皮肤填充剂市场报告将提供对大约 40 多个市场数据表、45 多个图表和 200 页（大约）的访问。

内容

第 1 章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 促进因素
      • 越来越重视美学
      • 对非手术面部矫正手术的需求
    • 抑制因素
      • 市场上假冒商品流通量增加
    • 商机
    • 影响分析

第 5 章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 可吸收真皮填充剂
  • 非吸收性真皮填充剂

第 8 章按材料分类

  • 透明质酸 (HA)
  • 聚乳酸 (PLA)
  • 羟基磷灰石钙 (CaH)
  • 聚甲基丙烯酸甲酯 (PMMA)
  • 胶原蛋白
  • 其他

第 9 章按应用程序

  • 面部线条矫正治疗
  • 撕掉
  • 疤痕治疗
  • 其他

第 10 章最终用户

  • 医院
  • 门诊手术中心
  • 皮肤科诊所
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 按类型进行基准测试

第 13 章公司简介

  • Allergan plc
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Galderma
  • Merz Pharma
  • Sinclair Pharma plc.
  • AQTIS Medical
  • Teoxane Laboratories
  • Cytophil Inc.
  • Cynosure
  • Dr. Korman Laboratories Ltd.
  • Advanced Aesthetic Technologies Inc.

第 14 章全球皮肤填充剂市场-DataM

简介目录
Product Code: DMPH1119

Market Overview

The global dermal fillers market size was growing at a CAGR of 11.10% during the forecast period (2022-2029).

Dermal fillers are injections that will plump up wrinkles and smooth lines on the face after taking it. Healthcare professionals generally inject dermal fillers in the areas near the eyes, mouth and nose. This expected cosmetic procedure typically delivers results directly and lasts months or years.

Market Dynamics

The global dermal fillers market is driven by technological advancements, the growing adoption of dermal fillers in medical aesthetics surgeries, improving patient awareness, and rising expenditure on cosmetic procedures.

Increasing awareness of medical aesthetics procedures in public drives market growth

The rising demand for anti-aging and increasing social media awareness drive the market in the forecast period. As per the article published in the Aesthetic Surgery Journal in April 2022, technological advances and widespread use of social media have increased awareness of diverse standards of beauty and aesthetic outcomes, ultimately broadening definitions of beauty and attractiveness and the consciousness of treatment goals. This dramatic rise in customer spending on cosmetic procedures has, in turn, generated promising prospects for the aesthetic medicine market in the future.

Approximately 70% of surveyed physicians indicated that their patients should seek aesthetic treatments in their 20s and 30s. Among aesthetically conscious female survey respondents, 32% indicated that they should seek treatment in their 30s, and 37% reported that they should seek treatment in their 40s.

In addition, in the era of social media, the dermal fillers market has developed to include a younger demographic with facial re-balancing. These treatments, aimed at the enhancement and preservation of youth rather than correcting age-related changes, include chin augmentation, lip plumping, liquid rhinoplasty, and gummy smile modification.

Moreover, dermal fillers are deployed to increase the face to meet the aesthetic concept of beauty, dictating that certain curves, contours, dimensions, and ratios are fulfilled to have a conventionally attractive face or to reform volumetric dimensions and hence youth in the aging face. Facial regeneration using soft tissue biodegradable fillers, a non-permanent injectable device, provides an affordable and relatively safe procedure compared to permanent surgical cosmetic procedures.

The side effects of dermal fillers will hamper the growth of the market

However, the side effects which tend to occur around the injection site can be immediate, including redness, swelling, pain, bruising, itching and rash. Rare side effects include leakage of the filler through the injection site, granulomas, infection, inflammatory reaction to the filler, nodules around the injection site, movement of the filler from one area to another, and injury to blood vessels. These side effects limit the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global medical aesthetics market. As per the article published in September 2022, cosmetic procedures and esthetic interventions are some luxurious lifestyles rather than a necessity. There has been a substantial reduction in procedures performed at the beginning of the COVID pandemic.

However, social distancing has led people to spend long hours on video calls, which promoted appearance dissatisfaction and sometimes evolution of dysmorphic thoughts about the body, especially the face; this has resulted in increased demand for esthetic and cosmetic procedures.

On the other hand, the SARS-CoV-2 infection and associated vaccines have given rise to several dermatologic reactions in those individuals who have previously undergone cosmetic surgery or esthetic interventions. Moreover, the demand for improving physical and mental self-acceptance usually increases after any disaster or crisis, and COVID-19 is no exception.

As of 2022, the market is recovering from COVID-19, and almost all people can access healthcare and cosmetic facilities, which drives the market worldwide.

Segment Analysis

The Hyaluronic Acid (HA) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The Hyaluronic Acid (HA) segment accounts for the largest market share. The popularity surge of injectable HA fillers has risen to in-vogue status. It has brought a concomitant gain in the incidence of once-rare iatrogenic vaso-occlusive injuries, from disfiguring facial skin necrosis to disabling neuro-ophthalmological sequelae.

As per the article published in Molecules 2022, dermal fillers have witnessed a surge in popularity in the two decades since HA injectable gels sales boomed by 700% between 2005 and 2020. As of 2022, the global market for cosmetic fillers registered a forecast of 65% by 2030.

The advent of chemically cross-linked hyaluronic acid (HA, hyaluronan) gel derivatives has indicated a new era in the biomedical arena, yielding novel therapeutic applications in surgery and regenerative medicine, and pharmacology. However, it is perhaps the utilization of hydro colloidal HA-based dermal fillers in aesthetic medicine that has witnessed the most significant growth in the last years. The explosion in the use of these injectable HA gels has brought a simultaneous rise in the incidence of subtle ischemic tissue infarcts stemming from the accidental intravascular injection of gel boluses, resulting in filler-induced vascular occlusion.

Geographical Analysis

North America region holds the largest market share of the global dermal fillers market

North America dominates the market for dermal fillers and is anticipated to show a similar trend over the forecast period. The market is driven by factors such as advanced healthcare infrastructure. The increasing awareness of medical aesthetics procedures, active regional key players, and easy availability of products in the region.

As per the article published in Molecules 2022, in the United States alone, approximately 3.4 million dermal filler procedures are performed yearly, with HA fillers comprising nearly 80% of filler products. This increased demand for cosmetic injectables stems from the growing acceptance of plastic surgery procedures across all age and gender groups, increased accessibility and marketing, and decreased cost of products, creating an increasingly competitive market likely to favor further adoption.

In addition, the market players are adopting the market strategies such as collaboration and product launches to expand their business. For instance, in May 2020, AbbVie acquired Allergan to expand its business. Allergan has a portfolio of brands and best-class products mainly focused on four key therapeutic areas: medical aesthetics, eye care, central nervous system and gastroenterology.

Competitive Landscape

The dermal fillers market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Allergan plc, Galderma, Merz Pharma, Sinclair Pharma plc, AQTIS Medical, Teoxane Laboratories, Cytophil Inc., Cynosure, Dr. Korman Laboratories Ltd., and Advanced Aesthetic Technologies Inc., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the dermal fillers market globally.

For instance,

  • In January 2020, Anika Therapeutics, Inc., a global, integrated joint conservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid technology platform, agreed to acquire Parcus Medical, a leading, privately-held sports medicine company, and Arthrosurface, a leading, privately-held provider of the joint surface and preservation solutions for active patients.

Allergan plc

Overview:

Allergan (part of Abbevie) is an American pharmaceutical company founded in 2013, and it produces products through advanced research to develop next-generation neuromodulator therapies and other treatments for neurological conditions.

Product Portfolio:

JUVEDERM: The JUVEDERM family of hyaluronic acid dermal fillers corrects moderate to severe facial wrinkles and folds.

The global dermal fillers market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing focus on aesthetics
      • 4.1.1.2. Demand for non-surgical procedures for facial correction
    • 4.1.2. Restraints:
      • 4.1.2.1. Growing circulation of counterfeit products in the market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Absorbable Dermal Fillers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Non-Absorbable Dermal Fillers

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 8.1.2. Market Attractiveness Index, By Material
  • 8.2. Hyaluronic Acid (HA)*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Poly-L-Lactic Acid (PLA)
  • 8.4. Calcium Hydroxylapatite (CaH)
  • 8.5. Polymethylmethacrylate (PMMA)
  • 8.6. Collagen
  • 8.7. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Facial Line Correction Treatment*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Lip Enhancement
  • 9.4. Scar Treatment
  • 9.5. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Dermatology Clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Type Benchmarking

13. Company Profiles

  • 13.1. Allergan plc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Galderma
  • 13.3. Merz Pharma
  • 13.4. Sinclair Pharma plc.
  • 13.5. AQTIS Medical
  • 13.6. Teoxane Laboratories
  • 13.7. Cytophil Inc.
  • 13.8. Cynosure
  • 13.9. Dr. Korman Laboratories Ltd.
  • 13.10. Advanced Aesthetic Technologies Inc.

LIST NOT EXHAUSTIVE

14. Global Dermal Fillers Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us